Search
for
Sort by
Research 781–810 of 1000+
- Elevated <em>DKK1</em> expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma
- Treatment options and emotional well-being in patients with rosacea: An unsupervised machine learning analysis of over 200,000 posts
- “Cellularity as a predictive tool for mesenchymal stem cell concentration in bone marrow concentrates: Implications for regenerative medicine”
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- 6601 A Case of Recurrent Painless Thyroiditis and Discussion of Management
- Post-marketing safety signals of four JAK inhibitors for alopecia areata: an indication-restricted FAERS pharmacovigilance study
- Development and validation of a patient‐reported outcome measure for hair loss treatment: The HAIR‐Q
- Exploring novel management options for alopecia areata
- Perspective Chapter: Beyond BMI – Rethinking Obesity Assessment in Women’s Health
- Rapid Screening of Anticoagulation Compounds for Biological Target-Associated Adverse Effects Using a Deep-Learning Framework in the Management of Atrial Fibrillation
- The Metaverse: A New Frontier in the Management of Hair Loss and Nail Disorders
- Knowledge, attitude, and practice of primary health physicians in Saudi Arabia in prescribing vitamins and minerals as treatment for hair loss
- Preclinical Pharmacology, Antitumor Activity, and Development of Pharmacodynamic Markers for the Novel, Potent AKT Inhibitor CCT128930
- Endogenous/exogenous stimuli‐responsive smart hydrogels for diabetic wound healing
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Strong efficacy of ritlecitinib 50 mg and baricitinib 4 mg in alopecia areata, but further research needed to establish superiority
- Establishing an Evidence-Based System for Cosmetic Safety and Efficacy Evaluation
- Response to Ranpariya et al.’s “Direct-to-consumer teledermatology platforms may have inherent conflicts of interest.”
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model
- Evolving treatment paradigms in dermatology: Insights from emerging and repurposed therapies
- The burden of alopecia areata: A scoping review focusing on quality of life, mental health and work productivity
- Efficacy and patient-reported outcomes in advanced non-small cell lung cancer patients receiving aumolertinib as first-line therapy: a real-world study
- Alopecia Areata Incognita: Current Evidence
- Comparative efficacy of minoxidil alone versus minoxidil combined with low-level laser therapy in the treatment of androgenic alopecia: a systematic review and meta-analysis
- Hair-bearing human skin generated entirely from pluripotent stem cells
- Real World Evidence in Alopecia Areata: Current Management, Emerging Therapies and Future Challenges – A Narrative Review
- Baseline Neutrophil-to-Lymphocyte Ratio Stratifies Early Trichoscopic Response to Platelet-Rich Plasma–Based Regimens in Non-Scarring Alopecia: A Real-World Cohort with Internal Validation Using an Interpretable Neural Network
- Identifying 17-β-HSD3 Deficiency in Patients with Karyotype 46,XY Misdiagnosed with Androgen Insensitivity Syndrome: A Pediatric Case Report
- Emergence of the natural history of Myhre syndrome: 47 patients evaluated in the Massachusetts General Hospital Myhre Syndrome Clinic (2016–2023)